Publicaciones en colaboración con investigadores/as de Carl von Ossietzky University of Oldenburg (2)

2024

  1. Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study

    Future oncology (London, England), Vol. 20, Núm. 6, pp. 297-306

2022

  1. Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

    Annals of Oncology, Vol. 33, Núm. 11, pp. 1168-1178